Substance / Medication

Bismuth subsalicylate

Overview

Active Ingredient
bismuth subsalicylate
RxNorm CUI
19478

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Consequences of Shigella infection in young children: a systematic review.
Libby Tanya E, Delawalla Miranda L M, Al-Shimari Fatima et al. · Int J Infect Dis · 2023
PMID: 36736579Meta-AnalysisFull text (PMC)
Antimicrobial resistance in sexually transmittedin men who have sex with men: A systematic review.
O'Flanagan Holly, Siddiq Mohammed, Llewellyn Carrie et al. · Int J STD AIDS · 2023
PMID: 36786731Meta-Analysis
Efficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023.
Angelo Kristina M, Salah Zainab, Rogova Marina et al. · J Travel Med · 2025
PMID: 40439228RCTFull text (PMC)
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.
Sheele Johnathan, Cartowski Jessica, Dart Angela et al. · Pathog Glob Health · 2015
PMID: 26260354RCTFull text (PMC)
Which place for bismuth subsalicylate in the treatment of enteric infections?
Guarino A, Bruzzese E · Acta Paediatr · 2001
PMID: 11440089Trial
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea.
Chowdhury H R, Yunus M, Zaman K et al. · Acta Paediatr · 2001
PMID: 11440090Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bismuth subsalicylate (substance)
SNOMED CT
82075003
UMLS CUI
C0053792
RxNorm CUI
19478

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.